Overview

This roundtable discussion with expert faculty will provide learners with the latest advances in diagnosing and managing patients with Homozygous Familial Hypercholesterolemia (HoFH). The goal of the activity is for learners to be better able to recognize the signs and symptoms of HoFH, the diagnostic criteria for this disease, the recommendations for cascade screening, as well as current strategies for individualizing treatment of HoFH in children and adults, including a review of angiopoietin-like 3 (ANGPTL3) inhibitors and it’s role in the management of HoFH.

Learning Objectives

1. Review the pathogenesis and progression of eosinophilic esophagitis (EoE).
2. Identify signs and symptoms associated with EoE and apply the latest guidelines to facilitate early diagnosis.
3. Assess the clinical risk-benefit profile of available and emerging therapies for EoE.
4. Apply current guidelines and evidence to individualize treatment plans for patients with EoE.

Target Audience

This activity will target gastroenterologists, including pediatric gastroenterologists as well as nurse practitioners, physician assistants and nurse specialists in GI care who treat of patients with EoE.

This activity is supported by an independent medical educational grant from Regeneron Pharmaceuticals Inc, and Sonofi.